The developing role of receptors and adaptors

Nature Reviews Cancer

Volumn 6, Issue 5, 2006, Pages 403-409

  Massie, Charles ^a   Mills, Ian G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETACELLULIN; CELL RECEPTOR; COLONY STIMULATING FACTOR 1; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; EPIREGULIN; ESTROGEN RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN MDM2; RNA BINDING PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR GAL4; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AMINO TERMINAL SEQUENCE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; ENDOCYTOSIS; ENDOSOME; HUMAN; INTERNALIZATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 33646378439     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1882     Document Type: Review

References (67)

1. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 (2000).
2. Le Roy, C. & Wrana, J. L. Signaling and endocytosis: a team effort for cell migration. Dev. Cell 9, 167-168 (2005).
3. Le Roy, C. & Wrana, J. L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nature Rev. Mol. Cell Biol. 6, 112-126 (2005).
4. McMahon, H. T. & Mills, I. G. COP and clathrin-coated vesicle budding: different pathways, common approaches. Curr. Opin. Cell Biol. 16, 379-391 (2004).
5. Mills, I. G. et al. Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors. J. Cell Biol. 170, 191-200 (2005).
6. Miaczynska, M. et al. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116, 445-56 (2004).
7. Lin, S. Y. et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biol. 3, 802-808 (2001).
8. Giri, D. K. et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol. Cell. Biol. 25, 11005-11018 (2005).
9. Lo, H. W. et al. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 7, 575-589 (2005).
10. Williams, C. C et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J. Cell Biol. 167, 469-478 (2004).
11. Wanker, E. E. et al. HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487-495 (1997).
12. Rao, D. S. et al. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell 3, 471-482 (2003).
13. Rao, D. S. et al. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J. Clin. Invest. 110, 351-360 (2002).
14. Chen, C. D. et al. Molecular determinants of resistance to antiandrogen therapy. Nature Med. 10, 33-39 (2004).
15. Raper, S. E., Burwen, S. J., Barker, M. E. & Jones, A. L. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 92, 1243-1250 (1987).
16. Marti, U. et al. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid 11, 137-145 (2001).
17. Lipponen, P. & Eskelinen, M. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis. Br. J. Cancer 69, 1120-1125 (1994).
18. Lo, H. W. et al. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 65, 338-348 (2005).
19. Wells, A. et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 247, 962-964 (1990).
20. Vieira, A. V., Lamaze, C. & Schmid, S. L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089 (1996).
21. Marti, U. & Hug, M. Acinar and cellular distribution and mRNA expression of the epidermal growth factor receptor are changed during liver regeneration. J. Hepatol. 23, 318-327 (1995).
22. Ni, C. Y., Murphy, M. P., Golde, T. E. & Carpenter, G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
23. Dittmann, K. et al. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem. 280, 31182-31189 (2005).
24. Prudovsky, I. A., Savion, N., LaVallee, T. M. & Maciag, T. The nuclear trafficking of extracellular fibroblast growth factor (FGF)-1 correlates with the perinuclear association of the FGF receptor-1α isoforms but not the FGF receptor-1β isoforms. J. Biol. Chem. 271, 14198-14205 (1996).
25. Mitsuuchi, Y. et al. Identification of a chromosome 3p14. 3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2. Oncogene 18, 4891-4898 (1999).
26. Habermann, B. The BAR-domain family of proteins: a case of bending and binding? EMBO Rep. 5, 250-255 (2004).
27. Altschuler, Y. et al. Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J. Cell Biol. 143, 1871-1881 (1998).
28. Saporita, A. J. et al. Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor. J. Biol. Chem. 278, 41998-42005 (2003).
29. Huppert, S. S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966-970 (2000).
30. Wilhelmsen, K. & van der Geer, P. Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol. Cell. Biol. 24, 454-464 (2004).
31. Maatta, J. A. et al. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol. Biol. Cell 17, 67-79 (2006).
32. Junttila, T. T. et al. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res. 65, 1384-1393 (2005).
33. Normanno, N. et al. The ErbB receptors and their ligands in cancer: an overview. Curr. Drug Targets 6, 243-257 (2005).
34. Vecchi, M., Baulida, J. & Carpenter, G. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J. Biol. Chem. 271, 18989-18995 (1996).
35. Rio, C., Buxbaum, J. D., Peschon, J. J. & Corfas, G. Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275, 10379-10387 (2000).
36. Vidal, G. A., Naresh, A., Marrero, L. & Jones, F. E. Presenilin-dependent γ-secretase processing regulates multiple ERBB4/HER4 activities. J. Biol. Chem. 280, 19777-19783 (2005).
37. Offterdinger, M., Schofer, C., Weipoltshammer, K. & Grunt, T. W. c-erbB-3: a nuclear protein in mammary epithelial cells. J. Cell Biol. 157, 929-939 (2002).
38. Fukui, S. et al. Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Cancer 97, 3061-3067 (2003).
39. Bryant, D. M., Wylie, F. G. & Stow, J. L. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol. Biol. Cell 16, 14-23 (2005).
40. Myers, J. M., Martins, G. G., Ostrowski, J. & Stachowiak, M. K. Nuclear trafficking of FGFR1: a role for the transmembrane domain. J. Cell. Biochem. 88, 1273-1291 (2003).
41. Stachowiak, M. K., Maher, P. A., Joy, A., Mordechai, E. & Stachowiak, E. K. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. Brain Res. Mol. Brain Res. 38, 161-165 (1996).
42. Tsai, B., Ye, Y. & Rapoport, T. A. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nature Rev. Mol. Cell Biol. 3, 246-255 (2002).
43. Rodighiero, C., Tsai, B., Rapoport, T. A. & Lencer, W. I. Role of ubiquitination in retro-translocation of cholera toxin and escape of cytosolic degradation. EMBO Rep. 3, 1222-1227 (2002).
44. Pelkmans, L., Kartenbeck, J. & Helenius, A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nature Cell Biol. 3, 473-483 (2001).
45. Pelkmans, L. & Helenius, A. Endocytosis via caveolae. Traffic 3, 311-320 (2002).
46. Mills, I. G., Urbe, S. & Clague, M. J. Relationships between EEA1 binding partners and their role in endosome fusion. J. Cell Sci. 114, 1959-1965 (2001).
47. Irvine, R. F. Nuclear lipid signalling. Nature Rev. Mol. Cell Biol. 4, 349-360 (2003).
48. Byrne, R. D. et al. Nuclear envelope assembly is promoted by phosphoinositide-specific phospholipase C with selective recruitment of phosphatidylinositol-enriched membranes. Biochem. J. 387, 393-400 (2005).
49. Larijani, B., Barona, T. M. & Poccia, D. L. Role for phosphatidylinositol in nuclear envelope formation. Biochem. J. 356, 495-501 (2001).
50. Barona, T. et al. Diacylglycerol induces fusion of nuclear envelope membrane precursor vesicles. J. Biol. Chem. 280, 41171-41177 (2005).
51. Vecchi, M. et al. Nucleocytoplasmic shuttling of endocytic proteins. J. Cell Biol. 153, 1511-1517 (2001).
52. Mroczkowski, B., Mosig, G. & Cohen, S. ATP-stimulated interaction between epidermal growth factor receptor and supercoiled DNA. Nature 309, 270-273 (1984).
53. Basu, M., Biswas, R. & Das, M. 42,000-molecular weight EGF receptor has protein kinase activity. Nature 311, 477-480 (1984).
54. Chen, H. H. et al. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 63, 1093-1100 (2005).
55. Vakkala, M. et al. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin. Cancer Res. 6, 2408-2416 (2000).
56. Clark, D. E. et al. ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events. J. Biol. Chem. 280, 24175-24180 (2005).
57. Dittmann, K., Mayer, C. & Rodemann, H. P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother. Oncol. 76, 157-161 (2005).
58. Baselga, J. The EGFR as a target for anticancer therapy - focus on cetuximab. Eur. J. Cancer 37, S16-S22 (2001).
59. Arasada, R. R. & Carpenter, G. Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. J. Biol. Chem. 280, 30783-30787 (2005).
60. Zhu, Y. et al. Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth promoting autocrine signal in breast tumor cells. Cancer Res. (in the press).
61. Hanada, N. et al. Co-regulation of B-Myb expression by E2F1 and EGF receptor. Mol. Carcinog. 45, 10-17 (2006).
62. Shelton, J. G. et al. The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it? Expert Opin. Ther. Targets 9, 1009-1030 (2005).
63. Wang, S. C. et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6, 251-261 (2004).
64. Howe, L. R. et al. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res. 65, 10113-10119 (2005).
65. Pelkmans, L. & Helenius, A. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15, 414-422 (2003).
66. Saint-Pol, A. et al. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev. Cell 6, 525-538 (2004).
67. Marti, U. & Wells, A. The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. Mol. Cell Biol. Res. Commun. 3, 8-14 (2000).